BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 14712291)

  • 1. In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
    Ramakers-van Woerden NL; Beverloo HB; Veerman AJ; Camitta BM; Loonen AH; van Wering ER; Slater RM; Harbott J; den Boer ML; Ludwig WD; Haas OA; Janka-Schaub GE; Pieters R
    Leukemia; 2004 Mar; 18(3):521-9. PubMed ID: 14712291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
    Pieters R; den Boer ML; Durian M; Janka G; Schmiegelow K; Kaspers GJ; van Wering ER; Veerman AJ
    Leukemia; 1998 Sep; 12(9):1344-8. PubMed ID: 9737681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
    Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
    Leukemia; 1993 Mar; 7(3):392-7. PubMed ID: 8445945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
    Ramakers-van Woerden NL; Pieters R; Hoelzer D; Slater RM; den Boer ML; Loonen AH; Harbott J; Janka-Schaub GE; Ludwig WD; Ossenkoppele GJ; van Wering ER; Veerman AJ;
    Med Pediatr Oncol; 2002 Jun; 38(6):379-86. PubMed ID: 11984797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage.
    Palle J; Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonsson OG; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G;
    Br J Haematol; 2005 Apr; 129(2):189-98. PubMed ID: 15813846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.
    Stam RW; den Boer ML; Meijerink JP; Ebus ME; Peters GJ; Noordhuis P; Janka-Schaub GE; Armstrong SA; Korsmeyer SJ; Pieters R
    Blood; 2003 Feb; 101(4):1270-6. PubMed ID: 12406912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
    Pui CH; Behm FG; Downing JR; Hancock ML; Shurtleff SA; Ribeiro RC; Head DR; Mahmoud HH; Sandlund JT; Furman WL
    J Clin Oncol; 1994 May; 12(5):909-15. PubMed ID: 8164041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
    Rubnitz JE; Camitta BM; Mahmoud H; Raimondi SC; Carroll AJ; Borowitz MJ; Shuster JJ; Link MP; Pullen DJ; Downing JR; Behm FG; Pui CH
    J Clin Oncol; 1999 Jan; 17(1):191-6. PubMed ID: 10458233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
    Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
    Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age.
    Behm FG; Raimondi SC; Frestedt JL; Liu Q; Crist WM; Downing JR; Rivera GK; Kersey JH; Pui CH
    Blood; 1996 Apr; 87(7):2870-7. PubMed ID: 8639906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
    den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ
    Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
    Wuchter C; Harbott J; Schoch C; Schnittger S; Borkhardt A; Karawajew L; Ratei R; Ruppert V; Haferlach T; Creutzig U; Dörken B; Ludwig WD
    Leukemia; 2000 Jul; 14(7):1232-8. PubMed ID: 10914547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23.
    Gill Super HJ; Rothberg PG; Kobayashi H; Freeman AI; Diaz MO; Rowley JD
    Blood; 1994 Feb; 83(3):641-4. PubMed ID: 8298125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children.
    Felix CA; Hosler MR; Slater DJ; Parker RI; Masterson M; Whitlock JA; Rebbeck TR; Nowell PC; Lange BJ
    J Pediatr Hematol Oncol; 1998; 20(4):299-308. PubMed ID: 9703001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features.
    Raimondi SC; Frestedt JL; Pui CH; Downing JR; Head DR; Kersey JH; Behm FG
    Blood; 1995 Sep; 86(5):1881-6. PubMed ID: 7655016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents.
    Nasr F; Macintyre E; Venuat AM; Bayle C; Carde P; Ribrag V
    Leuk Lymphoma; 1997 Apr; 25(3-4):399-401. PubMed ID: 9168451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
    Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M
    Leukemia; 2003 Apr; 17(4):700-6. PubMed ID: 12682627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia.
    von Bergh AR; Beverloo HB; Rombout P; van Wering ER; van Weel MH; Beverstock GC; Kluin PM; Slater RM; Schuuring E
    Genes Chromosomes Cancer; 2002 Sep; 35(1):92-6. PubMed ID: 12203795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
    Driessen EM; van Roon EH; Spijkers-Hagelstein JA; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW
    Haematologica; 2013 Jun; 98(6):937-44. PubMed ID: 23403319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).
    Taki T; Kano H; Taniwaki M; Sako M; Yanagisawa M; Hayashi Y
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14535-40. PubMed ID: 10588740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.